Skip to main content
SpringerLink
Log in

The clinical effectiveness of aspirin desensitization in chronic rhinosinusitis

  • Published:
Current Allergy and Asthma Reports Aims and scope Submit manuscript

Abstract

Aspirin-exacerbated respiratory disease (AERD) is a chronic inflammatory disease characterized by chronic rhinosinusitis, nasal polyposis, asthma, and airway reactivity to aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs). For patients who have inadequately controlled rhinosinusitis and/or asthma despite treatment with topical corticosteroids and leukotriene-modifying drugs, aspirin desensitization is an important therapeutic option. This review examines the evidence supporting the effectiveness of aspirin desensitization for the treatment of chronic rhinosinusitis in patients with AERD. Practical aspects of conducting safe aspirin desensitization procedures and optimizing therapeutic benefits are also reviewed. When conducted in accordance with current guidelines, aspirin desensitization is a safe procedure that allows patients with AERD who have an indication for aspirin or other NSAIDs to safely ingest these medications. There is now strong evidence that aspirin desensitization and daily aspirin therapy is effective for treatment of the chronic inflammatory disease of the upper airway and lower airways in AERD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Stevenson D, Sanchez-Borges M, Szczeklik A: Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxegenase enzymes. Ann Allergy Asthma Immunol 2001, 87:177–180.

    PubMed  CAS  Google Scholar 

  2. Szczeklik A, Nizankowska E, Duplaga M: Natural history of aspirin-induced asthma. Eur Respir J 2000, 16:423–426.

    Article  Google Scholar 

  3. Stevenson DD, Szczeklik A: Clinical and pathologic perspectives on aspirin sensitivity and asthma. J Allergy Clin Immunol 2006, 118:773–786.

    Article  PubMed  CAS  Google Scholar 

  4. Jenkins C, Costello J, Hodge L: Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ 2004, 328:434.

    Article  PubMed  CAS  Google Scholar 

  5. Weber RW, Hoffman M, Raine DA, Nelson HS: Incidence of bronchoconstriction due to aspirin, azo dyes, non-azo dyes, and preservatives in a population of perennial asthmatics. J Allergy Clin Immunol 1979, 64:32–37.

    Article  PubMed  CAS  Google Scholar 

  6. Daffern P, Muilenberg D, Hugli TE, Stevenson DD: Association of urinary leukotriene E4 excretion during aspirin challenges with severity of respiratory responses. J Allergy Clin Immunol 1999, 104:559–564.

    Article  PubMed  CAS  Google Scholar 

  7. Bochenek G, Nagraba K, Nizankowska E, Szczeklik A: A controlled study of 9alpha11beta-PGF2 (a PGD2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenges. J Allergy Clin Immunol 2003, 111:743–749.

    Article  PubMed  CAS  Google Scholar 

  8. Sanak M, Levy BD, Clish CB, et al.: Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics. Eur Respir J 2000, 16:44–49.

    Article  PubMed  CAS  Google Scholar 

  9. Schaefer D, Gode UC, Baenkler HW: Dynamics of eicosanoids in peripheral blood cells during bronchial provocation in aspirin-intolerant asthmatics. Eur Respir J 1999, 13:638–646.

    Article  Google Scholar 

  10. Szczeklik A: Prostaglandin E2 and aspirin-induced asthma. Lancet 1995, 345:1056.

    Article  PubMed  CAS  Google Scholar 

  11. Widal MF, Abrami P, Lermeyez J: Anaphylaxie et idiosyncrasie. Presse Med 1922, 30:189–192.

    CAS  Google Scholar 

  12. Stevenson DD, Simon RA, Mathison DA: Aspirin-sensitive asthma: tolerance to aspirin after positive oral aspirin challenges. J Allergy Clin Immunol 1980, 66:82–88.

    Article  PubMed  CAS  Google Scholar 

  13. Stevenson DD, Simon RA: Selection of patients for aspirin desensitization treatment. J Allergy Clin Immunol 2006, 118:801–804.

    Article  PubMed  Google Scholar 

  14. Macy E, Bernstein JA, Castells MC, et al.: Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper. Ann Allergy Asthma Immunol 2007, 98:172–174.

    PubMed  CAS  Google Scholar 

  15. Jenneck C, Juergens U, Buecheler M, Novak N: Pathogenesis, diagnosis, and treatment of aspirin intolerance. Ann Allergy Asthma Immunol 2007, 99:13–21.

    PubMed  CAS  Google Scholar 

  16. Picado C: Mechanisms of aspirin sensitivity. Curr Allergy Asthma Rep 2006, 6:198–202.

    Article  PubMed  CAS  Google Scholar 

  17. Mastalerz L, Milewski M, Duplaga M, et al.: Intranasal fluticasone propionate for chronic eosinophilic rhinitis in patients with aspirin-induced asthma. Allergy 1997, 52:895–900.

    Article  PubMed  CAS  Google Scholar 

  18. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: US Department of Health and Human Services; National Institutes of Health; National Heart, Lung, and Blood Institute; National Asthma Education and Prevention Program; 2007. [NIH publication no. 08-4051.]

    Google Scholar 

  19. Sladek K, Dworski R, Soja J, et al.: Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge. Am J Resp Crit Care Med 1994, 149:940–946.

    PubMed  CAS  Google Scholar 

  20. Dahlen B, Nizankowska E, Szczeklik A, et al.: Benefits of adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. Am J Respir Crit Care Med 1998, 157:1187–1194.

    PubMed  CAS  Google Scholar 

  21. Dahlen S, Malstrom K, Nizankowska E, et al.: Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo controlled trial. Am J Respir Crit Care Med 2002, 165:9–14.

    PubMed  Google Scholar 

  22. Berges-Gimeno M, Simon RA, Stevenson DD: The natural history and clinical characteristics of aspirin exacerbated respiratory disease. Ann Allergy Asthma Immunol 2002, 89:474–478.

    PubMed  Google Scholar 

  23. Slavin RG, Spector SL, Bernstein IL, et al.: The diagnosis and management of sinusitis: a practice parameter update. J Allergy Clin Immunol 2005, 116:S16–S47.

    Article  Google Scholar 

  24. Samter M, Beers RF Jr: Intolerance to aspirin: clinical studies and consideration of its pathogenesis. Ann Intern Med 1968, 68:975.

    PubMed  CAS  Google Scholar 

  25. McDonald JR, Mathison DA, Stevenson DD: Aspirin intolerance in asthma. J Allergy Clin Immunol 1972, 50:198.

    Article  PubMed  CAS  Google Scholar 

  26. Zeiss CR, Lockey RF: Refractory period to aspirin in a patient with aspirin-induced asthma. J Allergy Clin Immunol 1976, 57:440.

    Article  PubMed  CAS  Google Scholar 

  27. Stevenson DD, Pleskow WW, Simon RA, et al.: Aspirin-sensitive rhinosinusitis asthma: a double-blind crossover study of treatment with aspirin. J Allergy Clin Immunol 1984, 73:500–507.

    Article  PubMed  CAS  Google Scholar 

  28. Sweet JM, Stevenson DD, Simon RA, Mathison DA: Long-term effects of aspirin desensitization-treatment for aspirin-sensitive rhinosinusitis-asthma. J Allergy Clin Immunol 1990, 85:59–65.

    Article  PubMed  CAS  Google Scholar 

  29. Stevenson DD, Hankamer MA, Mathison DA, et al.: Aspirin desensitization of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes. J Allergy Clin Immunol 1996, 751–758.

  30. McMains KC, Kountakis SE: Medical and surgical considerations in patients with Samter’s triad. Am J Rhinol 2006, 20:573–576.

    Article  PubMed  Google Scholar 

  31. Berges-Gimeno MP, Simon RA, Stevenson DD: Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 2003, 111:180–186.

    Article  PubMed  CAS  Google Scholar 

  32. Berges-Gimeno MP, Simon RA, Stevenson DD: Early effects of aspirin desensitization treatment in asthmatic patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 2003, 90:338–341.

    PubMed  CAS  Google Scholar 

  33. Lee JY, Simon RA, Stevenson DD: Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 2007, 119:157–164.

    Article  PubMed  CAS  Google Scholar 

  34. Giampiero P, Bellioni P, Nucera E, et al.: Intranasal treatment with lysine acetylsalicylate in patients with nasal polyposis. Ann Allergy 1991, 67:588–592.

    Google Scholar 

  35. Parikh AA, Scadding GK: Intranasal lysine-aspirin in aspirin-sensitive nasal polyposis: a controlled trial. Laryngoscope 2005, 115:1385–1390.

    Article  PubMed  CAS  Google Scholar 

  36. Ogata N, Darby Y, Scadding G: Intranasal lysine-aspirin administration decreases polyp volume in patients with aspirin-intolerant asthma. J Laryngol Otol 2007, 121:1156–1160.

    Article  PubMed  CAS  Google Scholar 

  37. Lee JY, Simon RA: Does it make sense to “desens”? Aspirin desensitization in the treatment of chronic rhinosinusitis. Curr Allergy Asthma Reports 2006, 6:183–184.

    Article  Google Scholar 

  38. Berges-Gimeno MP, Simon RA, Stevenson DD: The effect of leukotriene-modifier drugs on aspirin-induced asthma and rhinitis reactions. Clin Exp Allergy 2002, 32:1491–1496.

    Article  PubMed  CAS  Google Scholar 

  39. White AA, Stevenson DD, Simon RA: The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 2005, 95:330–335.

    Article  PubMed  CAS  Google Scholar 

  40. Williams AN, Simon RA, Woessner KM, Stevenson DD: The relationship between historical aspirin-induced asthma and severity of asthma induced during oral aspirin challenges. J Allergy Clin Immunol 2007, 120:273–277.

    Article  PubMed  CAS  Google Scholar 

  41. Hooper L, Brown TJ, Elliott R, et al.: The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by nonsteroidal anti-inflammatory drugs: systematic review. BMJ 2004, 329:948.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Allergy, Asthma, and Immunology, Scripps Clinic, 3811 Valley Centre Drive, San Diego, CA, 92130, USA

    Adam N. Williams

Authors
  1. Adam N. Williams
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Katharine M. Woessner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adam N. Williams.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Williams, A.N., Woessner, K.M. The clinical effectiveness of aspirin desensitization in chronic rhinosinusitis. Curr Allergy Asthma Rep 8, 245–252 (2008). https://doi.org/10.1007/s11882-008-0041-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11882-008-0041-7

Keywords

Search

Navigation